Skip to content
Screener

Shattuck Labs, Inc. STTK Other Research And Development — Other research and development expense

Similar metrics at other companies

Arvinas logo
ARVNReportable Segment — Other research and development expense
$2.4M-22.6%
Zymeworks logo
ZYMEReportable Segment — Other research and development expense
$4.66M-22.2%
Archer Aviation logo
ACHRReportable Segment — Other research and development expense
$136.9M+44.7%
Solid Biosciences Inc. logo
SLDBExternal Research And Development Other — Other Research And Development Expense
$1.98M-36.4%
TG Therapeutics logo
TGTXOther Research And Development Expense
$87.27M+218%
XTI Aerospace, Inc. logo
XTIAADS — Other Research And Development Expense
$1.15M

Other financials

Income statement

See full
Revenue-
Operating income-$16.2M-24.0%
Net income-$15.2M-21.6%
EPS (diluted)-$0.12+50.0%

Balance sheet

See full
Cash & equivalents$63.3M+25.4%
Total debt$2.7M-10.0%
Total equity$211.1M+270%
Total assets$220.7M+243%

Cash flow

See full
Operating cash flow-$10.2M+2.4%
CapEx$78.0K
Free cash flow-$10.3M+1.6%

Valuation

See full
Market cap$681.93M+1,826%
Enterprise value$621.3M-5,241%
P/S681.9×+670×

Profitability

See full
Operating margin-5,578.7%-15,316pp
Net margin-5,256.8%-14,625pp
FCF margin-4,124%-23,818pp

Returns & leverage

See full
Return on equity-39.2%-12.5pp
Debt / equity0.0×
Current ratio27.6×+17.3×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherResearchAndDevelopmentExpense.

The source filing: Shattuck Labs, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 6:57 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-055483

2 Other research and development expense includes technical operations expense of $1.2 million and $0.7 million, research activities for other pipeline compounds and facility expenses of $0.8 million and $0.7 million and depreciation expense of $0.8 million and $0.9 million for the three months ended June 30, 2026 and 2025, respectively.

Item 1. Condensed Financial Statements (Unaudited)

FAQ

What is Shattuck Labs, Inc.'s other research and development — other research and development expense?
Shattuck Labs, Inc. (STTK) reported other research and development — other research and development expense of $800K in Q2 2026.
How has Shattuck Labs, Inc.'s other research and development — other research and development expense changed year-over-year?
Shattuck Labs, Inc.'s other research and development — other research and development expense increased by 14.3% year-over-year, from $700K to $800K.
What is the long-term trend for Shattuck Labs, Inc.'s other research and development — other research and development expense?
Over 2 years (2023 to 2025), Shattuck Labs, Inc.'s other research and development — other research and development expense has grown at a -41.4% compound annual growth rate (CAGR), from $9.9M to $3.4M.
What does other research and development — other research and development expense mean?
This metric aggregates miscellaneous research and development expenses, including facility costs and general research activities not directly tied to primary clinical trials. It serves as a proxy for the fixed and variable overhead required to sustain the broader research environment. Investors use this to understand the baseline operational burn rate associated with maintaining a research-focused biotechnology organization.

Ask your AI about Shattuck Labs, Inc.'s other research and development — other research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude